FDA — authorised 27 October 2004
- Application: NDA020958
- Marketing authorisation holder: KENVUE BRANDS
- Indication: Labeling
- Status: approved
FDA authorised Tums on 27 October 2004
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 27 October 2004; FDA authorised it on 6 February 2008.
KENVUE BRANDS holds the US marketing authorisation.